Kanakura, Yuzuru
276  results:
Search for persons X
?
1

End-of-treatment 18[F]-FDG PET can predict early progressio..:

Kato, Koji ; Izutsu, Koji ; Nishikori, Momoko...
International Journal of Hematology.  119 (2024)  6 - p. 677-685 , 2024
 
?
 
?
3

Real-world data on induction therapy in patients with trans..:

Shimura, Yuji ; Shibayama, Hirohiko ; Nakaya, Aya...
International Journal of Hematology.  118 (2023)  5 - p. 609-617 , 2023
 
?
4

Dose-escalation part of Phase I study of single-agent mosun..:

Munakata, Wataru ; Izutsu, Koji ; Mishima, Yuko...
Japanese Journal of Clinical Oncology.  53 (2023)  10 - p. 912-921 , 2023
 
?
 
?
6

Impaired B cell terminal differentiation in B cell-specific..:

Hamanaka, Yuri ; Tanimura, Akira ; Yokota, Takafumi...
Biochemical and Biophysical Research Communications.  603 (2022)  - p. 1-6 , 2022
 
?
8

ASXL1 mutations with serum EPO levels predict poor response..:

Morita, Yasuyoshi ; Nannya, Yasuhito ; Ichikawa, Motoshi...
International Journal of Hematology.  116 (2022)  5 - p. 659-668 , 2022
 
?
9

Real-world effectiveness and safety analysis of carfilzomib..:

Onda, Yoshiyuki ; Kanda, Junya ; Kaneko, Hitomi...
Therapeutic Advances in Hematology.  13 (2022)  - p. 204062072211045 , 2022
 
?
10

Long-term follow-up of patients with paroxysmal nocturnal h..:

Ikezoe, Takayuki ; Noji, Hideyoshi ; Ueda, Yasutaka...
International Journal of Hematology.  115 (2022)  4 - p. 470-480 , 2022
 
?
 
?
15

High numbers of programmed cell death-1-positive tumor infi..:

Saito, Hideaki ; Miyoshi, Hiroaki ; Shibayama, Hirohiko...
International Journal of Hematology.  114 (2021)  1 - p. 53-64 , 2021
 
1-15